Yale Cancer Center
LightNews LightNews
banner
yalecancer.bsky.social
Yale Cancer Center
@yalecancer.bsky.social
660 followers 130 following 670 posts
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians at Yale University and Smilow Cancer Hospital.
Posts Replies Media Videos
yalecancer.bsky.social
Tonight at 7:30pm on #YaleCancerAnswers, Dr. Henry Park joins the program to talk about the proliferation of cancer misinformation and scams on social media.
🔹 Listen live #wnpr
🔹 Download #ApplePodcasts
🔹 Listen later #YouTube
February 15, 2026 at 6:19 PM
yalecancer.bsky.social
Congratulations to #YaleCancerAnswers, our award-winning radio show and #podcast, which has added another honor to its portfolio. #FeedspotPodcast has named it as one of the top #Connecticut Medical Podcasts!
Learn more: medicine.yale.edu/cancer/news/...
February 13, 2026 at 5:09 PM
yalecancer.bsky.social
Meet Sheryl Roberts, PhD, who recently joined #YaleRadiology. Her lab develops chemical tools to identify disease locations for #PET imaging and theranostics to support #cancer treatment.
medicine.yale.edu/news-article...
Creating New Tools for Radioligand Therapy
Sheryl Roberts, PhD, has joined the faculty in the Department of Radiology and Biomedical Imaging as an assistant professor. Her new lab will develop chemical
medicine.yale.edu
February 13, 2026 at 3:06 PM
yalecancer.bsky.social
Thank you to Dr. Vijay Sankaran @bloodgenes.bsky.social
@bostonchildrens.bsky.social for presenting our annual Richard Frisbee, III Grand Rounds Lecture on how human genetic variation can teach us about #hematopoiesis.
@yale-hematology.bsky.social
February 12, 2026 at 6:49 PM
yalecancer.bsky.social
A new study by Dr. Mathieu Bakhoum has identified biological markers for a rare, aggressive #eyecancer that predict the likelihood of secondary tumors forming in the liver. #uvealmelanoma
medicine.yale.edu/news-article...
Eye Cancer Genes Predetermine Its Spread to the Liver
A new study has identified biomarkers on a rare, aggressive eye cancer that predict its future spread to the liver.
medicine.yale.edu
February 12, 2026 at 6:48 PM
yalecancer.bsky.social
In this review article, findings from Yale experts highlight the value of qualitative research for improving health outcomes for people with hematological disorders + their communities and present an expert-informed roadmap.
thelancet.com/journals/lan...
@thelancethaem.bsky.social
Expert recommendations for the conduct and appraisal of qualitative research in haematology
Haematological disorders constitute a public health crisis in more than 160 countries worldwide. Despite millions afflicted, people with haematological diagnoses remain underserved and understudied. T...
thelancet.com
February 12, 2026 at 1:08 PM
yalecancer.bsky.social
The @yalecancer.bsky.social Population Science Research Award, presented by Melinda Irwin, PhD, MPH, was awarded to Xuehong Zhang, PhD, for his study: "Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes," published in #NatureFood.
February 11, 2026 at 6:49 PM
yalecancer.bsky.social
New research from Dr. Kiran Turaga shows how in #colorectalcancer with peritoneal metastases, CMS4 tumors have unique drug sensitivities, highlighting the need for subtype-guided personalized #HIPEC strategies.
link.springer.com/article/10.1...
@annsurgoncology.bsky.social @jsheltzer.bsky.social
Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases - Annals of Surgical Oncology
Background Although hyperthermic intraperitoneal chemotherapy (HIPEC) added to cytoreductive surgery shows promise for colorectal cancer with peritoneal metastases (CRC-PM), effectiveness remains vari...
link.springer.com
February 11, 2026 at 5:11 PM
yalecancer.bsky.social
A new Yale-led study from @muschenlab.bsky.social
uncovers how some aggressive #leukemia cells rely on CD25 as a molecular brake. Removing it sends cells into overdrive and they die, revealing a new angle for cancer drug development.
medicine.yale.edu/cancer/news-...
@oncoalert.bsky.social
Yale Study Identifies a New Class of Drug Targets for Aggressive Leukemia
Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer’s
medicine.yale.edu
February 11, 2026 at 5:06 PM
yalecancer.bsky.social
Please join us at 12pm as Dr. Vijay Sankaran
@bloodgenes.bsky.social @bostonchildrens.bsky.social
presents #GrandRounds on the topic of "How Human Genetic Variation Can Teach Us About Hematopoiesis."
Join us in Smilow Auditorium or online via Zoom. bit.ly/4bHlJbB
February 10, 2026 at 2:29 PM
yalecancer.bsky.social
Research from Dr. Prasanna Ananth and her lab describes how a novel parent-reported questionnaire: “Pediatric Cancer Care Experience” (PACE) evaluates the quality + experiences of care in children with advanced #cancer.
sciencedirect.com/science/arti...
February 10, 2026 at 1:06 PM
yalecancer.bsky.social
New research led by Dr. Etienne Caron shows how #melanoma cells release pigment-containing particles that act as decoys, interfering with immune T cells’ ability to kill #cancer. Targeting this pathway may boost #immunotherapy success.
science.org/doi/10.1126/...
February 10, 2026 at 2:14 AM
yalecancer.bsky.social
Tonight at 7:30pm on #YaleCancerAnswers, Dr. Sarah Hull joins to discuss the field of cardio-oncology, including caring for patients with cancer with underlying cardiac problems and those who develop cardiac problems from cancer.
🎧Listen live #WNPR
🔁Download via #ApplePodcasts
💻Listen later #YouTube
February 8, 2026 at 7:47 PM
yalecancer.bsky.social
Don't miss our annual Post-ASH Review, hosted by
Dr. Natalia Neparidze, Friday, March 13. Our @yale-hematology.bsky.social experts will be sharing highlights and key takeaways from the American Society of Hematology’s Annual Meeting.
RSVP: bit.ly/3ZOATo6
February 7, 2026 at 8:58 PM
yalecancer.bsky.social
Drs. Diane Krause and Stephanie Halene (not pictured) were presented with the @yalecancer.bsky.social Basic Science Research Award for their research identifying new & promising targets for future treatments in patients with acute megakaryoblastic leukemia. #AMKL ashpublications.org/blood/articl...
February 6, 2026 at 3:58 PM
yalecancer.bsky.social
Join us for a 4-part CME webinar series hosted by
our Center for Gastrointestinal Cancers, every 3rd Thursday at 6:30pm through May.

🗓️Feb. 19- Rare GI Cancers
🗓️March 19- Colorectal Liver Metastases
🗓️April 16- Biliary Tract Cancers
🗓️May 21- Pancreas Cancer

➡️RSVP: bit.ly/45N4Atd
February 6, 2026 at 1:03 PM
yalecancer.bsky.social
Members of our Yale Thoracic Oncology and #LungCancerSPORE teams got together at Yale’s Ingalls Rink to take in some Yale Men's Hockey over the weekend!
February 4, 2026 at 4:07 PM
yalecancer.bsky.social
We hosted our National Clinical Trials Network #NCTN Summit last week to gather our #clinicalresearch teams, celebrate accomplishments, and discuss the year ahead. Hosted by Dr. Anne Chiang with @drdawnhershman.bsky.social @columbiacancer.bsky.social as keynote speaker, the day was a great success!
February 3, 2026 at 7:56 PM
yalecancer.bsky.social
We invite you to join us for #GrandRounds today at 12pm as
Dr. Gaorav Gupta @guptalabunc.bsky.social presents "Immunogenicity of DNA damage in #breastcancer prevention and therapy." Please join us in Smilow Auditorium or via Zoom: bit.ly/4qy6JRf.
February 3, 2026 at 2:15 PM
yalecancer.bsky.social
As demand for #genetictesting grows, the shortage of genetic counselors (GC) remains a barrier. A Yale-led “Fast-Track” model using trained coordinators under GC oversight cut wait times, while maintaining high-quality care.
onlinelibrary.wiley.com/doi/10.1002/...
Addressing the critical need for cancer genetic evaluation by implementation of an embedded coordinator‐based genetics alternative delivery model: The Fast‐Track Program
Indications for germline genetic testing (GT) for hereditary cancer predispositions have increased; however, a critical shortage of genetic counselors (GCs) necessitates the implementation of alterna....
onlinelibrary.wiley.com
January 30, 2026 at 7:18 PM
yalecancer.bsky.social
New research from Dr. Samir Zaidi with Dr. Michael Morris @mskcancercenter.bsky.social shows #PSMA expression can vary in #mCRPC, even in tumors that appear PSMA+ on imaging. Combining PSMA scans with blood-based biomarkers may help inform treatment decision–making.
aacrjournals.org/clincancerre...
January 30, 2026 at 1:10 PM
yalecancer.bsky.social
Drs. John Kunstman and Jonathan Cardella presented #GrandRounds to share the role of #oncovascular surgery at Yale and options for patients with locally advanced #pancreaticcancer.
➡️Watch their full talk youtube.com/watch?v=9C1m....
January 29, 2026 at 6:31 PM
yalecancer.bsky.social
Join Drs. Barbara Burtness, Aarti Bhatia, and Ranee Mehra from the University of Maryland for an in-person or virtual #HNSCC program exploring approaches to care for patients with recurrent/metastatic head and neck squamous cell carcinoma.
RSVP: bit.ly/MHNCS26-T
@peerview.bsky.social
January 29, 2026 at 1:59 PM
yalecancer.bsky.social
A Yale-led genetic study of rare endometrial stromal sarcoma #ESS uncovers new treatment possibilities. “Our findings may represent a potentially effective treatment for a subset of these patients,” -Dr. Alessandro Santin.
medicine.yale.edu/cancer/news-...
Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments
Researchers uncovered potential treatment strategies for stromal sarcoma of the uterus by establishing a more detailed understanding of the aggressive tumors at
medicine.yale.edu
January 28, 2026 at 3:03 PM
yalecancer.bsky.social
Dr. Maureen Canavan joined 'JCO After Hours' with @drkerinadelson.bsky.social to discuss their article: "Association Between Systemic Anticancer Therapy Administration Near the End of Life with Health Care and Hospice Utilization in Older Adults.”
ascopubs.org/do/associati...
@ascocancer.bsky.social
January 28, 2026 at 1:16 PM